Media
Company news
ChemDiv Expands Modeling & Simulation Services Platform, Signs Tenth Collaborator in 2026 - Mondego Bio
ChemDiv today announced the continued expansion of its Modeling & Simulation Services platform, highlighted by the signing of its tenth collaborator in 2026, Mondego Bio (Coimbra, Portugal), f...
Pop-Science
RNA Inhibitors: Small Molecules Targeting RNA | ChemDiv Libraries
Explore the new frontier of RNA Inhibitors and small molecules targeting RNA. Discover mechanisms, scientific validation, and purchase specialized screening libraries at ChemDiv.
ChemDiv in Publications
ChemDiv Company in publications and patents
We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area.
It means a lot to us if our custome...
Pharma News
Johnson & Johnson Reports 73% PSA Response with Pasritamig Combination
Johnson & Johnson reports 73% of evaluable patients achieved at least 50% PSA reduction with pasritamig and JNJ-9401 in a Phase 1 prostate cancer study.
Follow us: